PRESS RELEASE published on 06/26/2025 at 17:40, 7 months 17 days ago VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 6,9 M€ entièrement dédiée à soutenir l’expansion commerciale de son offre de compléments alimentaires Valbiotis annonce le succès de son augmentation de capital de 6,9 M€ pour l'expansion commerciale de ses compléments alimentaires. Sébastien PELTIER souscrit à l'opération Augmentation De Capital Valbiotis Compléments Alimentaires Expansion Commerciale Sébastien Peltier
BRIEF published on 06/06/2025 at 08:05, 8 months 8 days ago Valbiotis Announces Capital Increase of €6.9 Million Capital Increase Valbiotis Dietary Supplements Subscription Rights Commercial Strategy
BRIEF published on 06/06/2025 at 08:05, 8 months 8 days ago Valbiotis annonce une augmentation de capital de 6,9 millions d'euros Augmentation De Capital Valbiotis Compléments Alimentaires Stratégie Commerciale Droits De Souscription
PRESS RELEASE published on 06/06/2025 at 08:01, 8 months 8 days ago VALBIOTIS SA: Valbiotis annonce le lancement d’une augmentation de capital avec maintien du DPS d’un montant de 6,9 M€ sécurisée par des engagements à hauteur de 75,0%
PRESS RELEASE published on 06/06/2025 at 08:00, 8 months 8 days ago VALBIOTIS SA: Valbiotis annonce le lancement d’une augmentation de capital avec maintien du DPS d’un montant de 6,9 M€ sécurisée par des engagements à hauteur de 75,0% Valbiotis SA annonce une augmentation de capital de 6,9 M€ avec maintien du DPS sécurisée par des engagements à 75,0% pour financer sa stratégie commerciale et son développement. Prix de souscription à 0,88 € par action Augmentation De Capital Valbiotis Stratégie Commerciale Engagements DPS
PRESS RELEASE published on 06/06/2025 at 08:00, 8 months 8 days ago VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained preferential subscription rights for a gross amount of nearly €6.9 million, secured by subscription commitments of 75 Valbiotis announces a capital increase of nearly €6.9 million with preferential subscription rights, aiming to finance its commercial strategy and sales growth of health supplements. Subscription period from 12 to 24 June 2025 Capital Increase Valbiotis Subscription Rights Commercial Strategy Health Supplements
BRIEF published on 06/02/2025 at 22:53, 8 months 11 days ago Valbiotis : Informations sur le Capital Social et Droits de Vote Droits De Vote Capital Social Euronext Growth Valbiotis Règlement AMF
BRIEF published on 06/02/2025 at 22:53, 8 months 11 days ago Valbiotis: Information on Share Capital and Voting Rights Share Capital Voting Rights Euronext Growth Valbiotis AMF Regulation
BRIEF published on 06/02/2025 at 22:53, 8 months 11 days ago VALBIOTIS: Information on Share Capital and Voting Rights Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF published on 06/02/2025 at 22:53, 8 months 11 days ago VALBIOTIS : Informations sur le Capital Social et les Droits de Vote Droits De Vote Franchissement De Seuil Capital Social Euronext Growth Valbiotis
Published on 02/14/2026 at 01:00, 10 hours 10 minutes ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 12 hours 55 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 17 hours 25 minutes ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 20 hours 35 minutes ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 06:05, 5 hours 5 minutes ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 15 hours 50 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 16 hours 9 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 16 hours 50 minutes ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:07, 17 hours 2 minutes ago EQS-Adhoc: Delticom AG: Based on preliminary, unaudited figures for the FY 2025, full-year revenues are below the forecast, while operating EBITDA is expected to be at the upper end of the forecasted range
Published on 02/13/2026 at 18:05, 17 hours 5 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 17 hours 5 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 17 hours 20 minutes ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 17 hours 20 minutes ago Nombre total d'actions et droits de vote - janvier 2026